Latest Trials Latest NewsFAQ

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Cord Blood Transplantation for Patients With Cancer

Phase 2

Terminated

Conditions: Hematological Disease

Interventions: Drug: Melphalan
Drug: Antithymocyte Globulin (ATG)
Drug: Fludarabine
Drug: Busulfan
Drug: Total Body Irradiation (TBI)

First Posted Date: 2011-05-24

Last Posted Date: 2015-04-30

Lead Sponsor: University of Chicago

Target Recruit Count: 1

Registration Number: NCT01359254

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer

Early Phase 1

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: 99mTc-EC-DG

First Posted Date: 2011-05-24

Last Posted Date: 2020-05-08

Lead Sponsor: University of Chicago

Target Recruit Count: 12

Registration Number: NCT01359267

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer

Phase 1

Conditions: Pancreatic Cancer

Interventions: Radiation: Stereotactic Radiation

First Posted Date: 2011-04-27

Last Posted Date: 2021-04-01

Lead Sponsor: University of Chicago

Target Recruit Count: 17

Registration Number: NCT01342354

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer

Not Applicable

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Drug: Bicalutamide
Drug: Dutasteride
Drug: Finasteride
Radiation: Radiation

First Posted Date: 2011-04-27

Last Posted Date: 2024-05-24

Lead Sponsor: University of Chicago

Target Recruit Count: 74

Registration Number: NCT01342367

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Comparison of Two Lidocaine Administration Techniques

Phase 4

Completed

Conditions: Pain

Interventions: Drug: lidocaine

First Posted Date: 2011-04-06

Last Posted Date: 2018-07-26

Lead Sponsor: University of Chicago

Target Recruit Count: 481

Registration Number: NCT01330134

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

Health and Faith (Salud y Fe): Community-Based Diabetes Pilot Intervention

Not Applicable

Completed

Conditions: Diabetes

Interventions: Behavioral: Picture good health/Imaginate una buena salud
Behavioral: Diabetes lecture

First Posted Date: 2011-02-02

Last Posted Date: 2013-09-24

Lead Sponsor: University of Chicago

Target Recruit Count: 100

Registration Number: NCT01288300

Locations: 🇺🇸
Our Lady of Tepeyac Church, Chicago, Illinois, United States
🇺🇸
Centro de Salud y Esperanza, Chicago, Illinois, United States
🇺🇸
St. Agnes of Bohemia Church, Chicago, Illinois, United States

Observational Study of Blood Pressure Measurements and Continuous Dialysis

Terminated

Conditions: Critical Illness
Kidney Failure
Respiratory Failure
Shock

First Posted Date: 2011-01-31

Last Posted Date: 2016-08-31

Lead Sponsor: University of Chicago

Target Recruit Count: 7

Registration Number: NCT01286506

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Recruiting

Conditions: Patients Undergoing Routine Health Care
Autoimmune Disease
Hepatitis C
Non-Metastatic Neoplasm
Heart Diseases
Inflammatory Bowel Diseases
Blood Coagulation Disorders
Inflammatory Disease

First Posted Date: 2011-01-21

Last Posted Date: 2024-01-29

Lead Sponsor: University of Chicago

Target Recruit Count: 1200

Registration Number: NCT01280825

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention (ARIVE-PCI) Registry

Active, not recruiting

Conditions: Coronary Artery Disease

First Posted Date: 2011-01-17

Last Posted Date: 2023-05-06

Lead Sponsor: University of Chicago

Target Recruit Count: 100

Registration Number: NCT01278043

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Patient Satisfaction and Safety Outcomes After Enrollment in a Same-Day (SD) Percutaneous Coronary Intervention Program

Completed

Conditions: To Evaluate Clinical Outcomes, Safety, and Satisfaction of Patients Who Have Participated in a Same Day Outpatient Percutaneous Coronary Artery Intervention

First Posted Date: 2011-01-13

Last Posted Date: 2023-04-26

Lead Sponsor: University of Chicago

Target Recruit Count: 59

Registration Number: NCT01276132

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy